Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 18.65
-0.24 (-1.27%)
Sep 24, 2026, 10:14 AM CST
Jiangsu Gdk Biological Technology Company Description
Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines.
It offers quadrivalent influenza virus split vaccines. The company human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia.
Jiangsu Gdk Biological Technology Co., Ltd was founded in 2008 and is based in Taizhou, China.
Jiangsu Gdk Biological Technology Co., Ltd
| Country | China |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 357 |
| CEO | Liangbin Zhang |
Contact Details
Address: No. 12 Yujin Road Taizhou, 225300 China | |
| Phone | 86 523 8620 5860 |
| Website | gdkbio.com |
Stock Details
| Ticker Symbol | 688670 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004NR4 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Liangbin Zhang | GM and Director |
| Qiang Huang | Financial Director and Accounting Supevisor |
| Jianguo Xia | Deputy GM and Director |
| Jin Zhou | Secretary to the Board |
| Guo Xiong Tian | Deputy General Manager |
| Jing Yu Zou | Deputy General Manager |